In this episode Dr. Courtney Miller, a neuroscientist and co-founder of Myosin, discusses her journey in drug development for substance use disorder and glioblastoma. She shares how her team discovered a potential treatment for methamphetamine addiction and the progress they have made in developing it into a medication. Dr. Miller also highlights the challenges of fundraising in the biotech industry, particularly for areas like substance use disorder and glioblastoma. She emphasizes the importance of networking and self-promotion, especially for women in the field. Dr. Miller envisions bringing their treatments into the clinic and making a significant impact in the next five years.
neuroscience, drug development, substance use disorder, addiction, glioblastoma, fundraising, networking, self-promotion, biotech industry
Drug development for substance use disorder and glioblastoma is a challenging and expensive journey.
Networking and self-promotion are crucial for success in the biotech industry, especially for women.
Taking advantage of opportunities and building a strong network can lead to unexpected career paths.
Stigma surrounding substance use disorder hinders progress in developing effective treatments.
Creating a narrative and leveraging personal connections can open doors and lead to valuable collaborations.
Dr. Miller aims to bring their treatments into the clinic and make a significant impact in the next five years.
Making a Significant Impact in Drug Development
Challenges of Fundraising in the Biotech Industry
00:00 Introduction and Background
02:47 Discovery of Potential Treatment for Methamphetamine Addiction
08:23 Understanding Substance Use Disorder and Brain Changes
13:09 Challenges and Opportunities in Fundraising
20:22 The Importance of Networking and Self-Promotion
27:10 Overcoming Stigma and Building Strong Connections
35:43 Future Goals and Impact in Drug Development